{"database": "lobbying", "table": "lobbying_activities", "rows": [[3246304, "efda9ea2-2f51-4a0a-97bd-c33e29a1dc7e", "Q3", "FORBES-TATE", 400976792, "PHRMA", 2024, "third_quarter", "PHA", "Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2024-10-17T20:55:14-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3246304"], "units": {}, "query_ms": 45.95330310985446, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}